跳至主要内容
临床试验/ACTRN12613001171707
ACTRN12613001171707已完成未知

ovel brain biomarkers of driving and vigilance performance in obstructive sleep apnea during extended wakefulness

Woolcock Institute of Medical Research0 个研究点目标入组 58 人开始时间: 2013年10月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
25 Years 至 65 Years(—)
性别
All

入选标准

  • Age 25-65 years
  • Weight <150kg
  • PSG confirmed moderate to severe obstructive sleep apnea with an Apnea Hypopnea Index (AHI) of =15 events/hr and an Oxygen Desaturation Index (ODI) of =3% with =10 events/hr
  • Ability to read and speak English
  • Ability to perform neurobehavioural tests

排除标准

  • Other PSG confirmed sleep disorders
  • OSA patients with clinically significant uncontrolled co-morbidity such as: cardiac failure, hypertension, hypercapnia, COPD, Type 1 diabetes
  • History of head injury or psychiatric/neurological disorders: clinical depression, epilepsy, mania or psychosis, stroke
  • Currently using CNS active medications/drugs such as: anti-depressives, anti-psychotics, opiates, antihistamines

研究者

相似试验

ovel brain biomarkers of performance impairment in... | 临床试验